1
|
Schaarup JR, Christensen MS, Hulman A, Hansen CS, Vistisen D, Tabák AG, Witte DR, Bjerg L. Autonomic dysfunction is associated with the development of arterial stiffness: the Whitehall II cohort. GeroScience 2023; 45:2443-2455. [PMID: 37074615 PMCID: PMC10651635 DOI: 10.1007/s11357-023-00762-0] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/04/2022] [Accepted: 02/23/2023] [Indexed: 04/20/2023] Open
Abstract
This study aims to examine the association between baseline level and change of autonomic nervous function with subsequent development of arterial stiffness. Autonomic nervous function was assessed in 4901 participants of the Whitehall II occupational cohort by heart rate variability (HRV) indices and resting heart rate (rHR) three times between 1997 and 2009, while arterial stiffness was assessed by carotid-femoral pulse wave velocity (PWV) measured twice between 2007 and 2013. First, individual HRV/rHR levels and annual changes were estimated. Then, we modelled the development of PWV by HRV/rHR using linear mixed effect models. First, we adjusted for sex and ethnicity (model 1), and then for socioeconomic and lifestyle factors, various clinical measurements, and medications (model 2). A decrease in HRV and unchanged rHR was associated with subsequent higher levels of PWV, but the effect of a change in HRV was less pronounced at higher ages. A typical individual aged 65 years with a SDNN level of 30 ms and a 2% annual decrease in SDNN had 1.32 (0.95; 1.69) higher PWV compared to one with the same age and SDNN level but with a 1% annual decrease in SDNN. Further adjustment had no major effect on the results. People who experience a steeper decline in autonomic nervous function have higher levels of arterial stiffness. The association was stronger in younger people.
Collapse
Affiliation(s)
- Jonas R Schaarup
- Department of Public Health, Aarhus University, Bartholins Allé 2, 8000, Aarhus, Denmark.
- Steno Diabetes Center Aarhus, Aarhus University Hospital, Palle Juul-Jensens Boulevard 11, 8200, Aarhus, Denmark.
| | - Martin S Christensen
- Aarhus University Hospital, Palle Juul-Jensens Boulevard 161, 8200, Aarhus, Denmark
| | - Adam Hulman
- Department of Public Health, Aarhus University, Bartholins Allé 2, 8000, Aarhus, Denmark
- Steno Diabetes Center Aarhus, Aarhus University Hospital, Palle Juul-Jensens Boulevard 11, 8200, Aarhus, Denmark
| | - Christian S Hansen
- Steno Diabetes Center Copenhagen, Ib Juuls Vej 83, 2730, Herlev, Denmark
| | - Dorte Vistisen
- Steno Diabetes Center Copenhagen, Ib Juuls Vej 83, 2730, Herlev, Denmark
- Department of Public Health, University of Copenhagen, Øster Farimagsgade 5, 1353, Copenhagen, Denmark
| | - Adam G Tabák
- Department of Epidemiology and Public Health, University College London, 1-19 Torrington Place, London, UK
- Department of Public Health, Semmelweis University Faculty of Medicine, 26 Üllői Str., 1085, Budapest, Hungary
- Department of Internal Medicine and Oncology, Semmelweis University Faculty of Medicine, 26 Üllői Str., 1085, Budapest, Hungary
| | - Daniel R Witte
- Department of Public Health, Aarhus University, Bartholins Allé 2, 8000, Aarhus, Denmark
- Steno Diabetes Center Aarhus, Aarhus University Hospital, Palle Juul-Jensens Boulevard 11, 8200, Aarhus, Denmark
| | - Lasse Bjerg
- Department of Public Health, Aarhus University, Bartholins Allé 2, 8000, Aarhus, Denmark
- Steno Diabetes Center Aarhus, Aarhus University Hospital, Palle Juul-Jensens Boulevard 11, 8200, Aarhus, Denmark
| |
Collapse
|